New AHA studies reveal a powerful cholesterol drug and CAR T therapy that significantly reduce heart disease risk, even before a heart attacks or stroke occurs.
Scientists presented groundbreaking studies at the American Heart Association (AHA) Scientific Sessions that could dramatically change the future of heart disease prevention — especially for people who have never experienced a heart attacks or stroke but remain at high risk.
Heart disease continues to be the leading cause of death worldwide, and experts say the only way to reduce this burden is by targeting risk factors earlier and more aggressively.
Cholesterol Drug Shows Major Heart Protection Before First Attack
One of the most discussed studies was the Vesalius-CV trial, which tested a new cholesterol-lowering drug in patients who had not yet suffered cardiovascular events.
According to Dr. Nishant Shah from Duke University Medical Center:
“We saw profound reductions in cardiovascular events in a group that does not usually receive aggressive treatment.”
This reinforces the message that early prevention is crucial — particularly for:
- Young adults with high cholesterol
- People with a family history of heart disease
- Individuals with obesity or high blood pressure
- People living unhealthy lifestyles
Doctors are alarmed by the increasing number of heart attacks among younger people, and Shah believes medical care must shift from reactive treatments to proactive protection.
Other research at the conference also highlighted:
- Better management of hypertension
- Preventing obesity early
- Lifestyle changes for long-term heart health
- New technologies for cholesterol control
There was even curiosity about whether daily coffee consumption could prevent abnormal heart rhythms from returning — though scientists say more evidence is needed before making recommendations.
Next-Level Heart Treatment: CAR T Cells Reduce Plaque by 70% in Mice
In another exciting development, researchers at the Perelman School of Medicine, University of Pennsylvania tested CAR T cell therapy — normally used to fight cancer — to treat atherosclerosis, the most common form of heart disease.
This treatment uses regulatory T cells (Tregs) to fight inflammation triggered by oxidized LDL (OxLDL) — the harmful cholesterol responsible for plaque buildup inside arteries.
In mouse studies, the therapy:
- Reduced arterial plaque by about 70%
- Prevented harmful immune reactions
- Improved blood flow without weakening immunity
Study leader Dr. Avery Posey said:
“This is the first time CAR T technology has been used to attack the root cause of the world’s most common deadly disease.”
Researchers have already created a biotech startup — Cartio Therapeutics — to further develop the treatment for human trials.
Why This Matters — Especially for Cancer Survivors
There is a strong link between cancer, inflammation, and heart disease.
Many cancer survivors remain at high risk of heart attacks because:
- Some cancer treatments damage the heart
- Cancer itself can increase inflammation
Lead researcher Dr. Robert Schwab explained:
“It’s painful to see a patient overcome cancer only to die of a heart attack later.”
This new therapy might protect cancer survivors along with millions of others at high risk.
Experts Caution: More Data Needed
While the results are promising, scientists stress that human trials will take time. These treatments are still in early stages, and doctors do not want people to stop using proven therapies such as:
- Statins
- Blood pressure medicines
- Lifestyle changes (diet + exercise)
These studies show that science is moving toward a future where:
- Heart disease can be prevented long before damage begins
- New therapies target inflammation — not just cholesterol
- Younger adults could avoid early heart attacks
- Cancer survivors may gain longer, healthier lives
Doctors advise everyone to check their personal heart risk regularly with a medical provider.
👉Read More Health & Fitness Blogs:
To get instant health & Fitness blogs notifications like this! Join the WhatsApp & Telegram groups. Click to Join Below Button 👇